| Title | BMC Cancer |
| Standard Abbreviation | BMC Cancer |
| Type of Publication | Journal |
| Discipline | Genetics (Q1); Cancer Research (Q2); Oncology (Q2) |
| Impact Score | 3.72 |
| SCImago Journal Rank (SJR) | 1.137 |
| h-index | 149 |
| Overall Rank | 3385 |
| Publisher Name | BioMed Central Ltd. |
| Publication Country | United Kingdom |
| International Standard Serial Number (ISSN) | 14712407 |
| Coverage and History | 2001-2022 |
| Best Quartile | Q1 |
| Total Citations Received (Last 3 Year) |
16111 |
BMC Cancer is a journal published by BioMed Central Ltd.. This journal covers the area[s] related to Genetics, Cancer Research, Oncology, etc.
The coverage history of this journal is as follows: 2001-2022.
The rank of this journal is 3385. This journal's impact score, h-index, and SJR are 3.72, 149, and 1.137, respectively. The ISSN of this journal is/are as follows: 14712407.
The best quartile of BMC Cancer is Q1.
This journal has received a total of 16111 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the BMC Cancer is 3.72. It is computed in the year 2023 as per its definition and based on Scopus data.
3.72
It is decreased by a factor of around 0.69, and the percentage change is -15.65% compared to the preceding year 2021, indicating a falling trend.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of BMC Cancer is 3.72. If a similar downward trend continues, IS may decrease in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.72 |
| 2021 | 4.41 |
| 2020 | 4.06 |
| 2019 | 3.22 |
| 2018 | 3.10 |
| 2017 | 3.49 |
| 2016 | 3.61 |
| 2015 | 3.70 |
| 2014 | 3.91 |
The h-index of BMC Cancer is 149. By definition of the h-index, this journal has at least 149 published articles with more than 149 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of BMC Cancer is/are as follows: 14712407.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The BMC Cancer is ranked 3385 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 1.137.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of BMC Cancer is BioMed Central Ltd.. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2001-2022.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
The International Organization for Standardization 4 (ISO 4) abbreviation of BMC Cancer is BMC Cancer
3.72
1.137
149
3385
